Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Why economic indicators matter to investors: indicators help assess health, predict trends, and guide decisions, improving timing and risk management.
27,651 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
Automotive AI software leads the market today as BlackBerry and Mobileye rally on platform milestones, while NVIDIA d...
SpaceX launched an AI-focused IPO that stunned markets, with shares jumping 19% and a $2.2 trillion valuation. Analys...
When blue-chip allocators signal interest in a landmark IPO, it reshapes how individual investors view the stock. Thi...
A week of trouble tested Amazon's operations and investor nerves. This article breaks down two essential takeaways an...
SpaceX’s IPO filing reveals a company pivoting from rockets to AI infrastructure, with heavy spending and a long road...
As investors weigh a high-priced AR launch, the stock market today, june shows how one product can ripple across sent...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
As Berkshire Hathaway enters a new chapter, investors wonder if berkshire's just break from Buffett's time-tested pla...
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...
BOTZ remains the top pure-play robotics ETF, offering global robotics exposure, but its 40% top-name concentration an...